Damona Pharmaceuticals is a startup based in the United States, 1 tracked investor.
Damona Pharmaceuticals is a startup based in the United States. Brouky records 1 investor associated with the company.
Damona Pharmaceuticals is developing small-molecule precision neuromedicines to treat cognitive deficits associated with neurodegenerative and psychiatric disorders. Its lead candidate, DPX-101, is a positive allosteric modulator targeting the α5-GABA-A receptor for indications such as Alzheimer’s disease, depression, and schizophrenia.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.